Filing Details
- Accession Number:
- 0001127602-14-007555
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-21 08:06:45
- Reporting Period:
- 2014-02-19
- Filing Date:
- 2014-02-21
- Accepted Time:
- 2014-02-21 08:06:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219016 | W Michael Bonney | 65 Hayden Avenue Lexington MA 02421 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-19 | 9,500 | $0.00 | 171,597 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-20 | 3,112 | $75.60 | 168,485 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2014-02-19 | 9,500 | $0.00 | 9,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,000 | 2014-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,603 | Indirect | 401(k) Plan |
| Common Stock | 600 | Indirect | Trusts |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- This transaction was executed in multiple trades at prices ranging from $75.6000 to $75.6125. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to privde upon request to the SEC staff, the issuer or a secruity holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
- The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.
Billionaire Hedge Funds
